IU Health Goshen Center for Cancer Care
Research & Clinical Trials
We use research to continuously redefine how we fight cancer at Indiana University Health Goshen Center for Cancer Care. Our resolve to end cancer, once and for all, drives us to the leading edge of cancer care. It also provides our patients with the most innovative treatments available.
Pushing the limits
Clinical trials are the key to finding ways to improve health and cancer care. Each study tries to answer scientific questions and to find better ways to prevent, diagnose or treat cancer, as well as improve quality of life for cancer survivors.
You can use the following list to learn more about clinical trials open to patients at IU Health Goshen Center for Cancer Care.
Colon and Rectum Cancer
Esophageal and Stomach Cancer
Head and Neck Cancer
Lymphoma and Blood Cancer
All Other Cancers
Advancing toward cures
As a volunteer in a cancer clinical trial at IU Health Goshen Center for Cancer Care, you may benefit from a new drug, procedure or symptom-control method, while helping scientists evaluate its effectiveness. Your participation may also contribute directly to finding better ways to prevent, detect or treat diseases.
Some clinical trials only include patients who have not yet received treatment. Other trials test treatments for patients who have not gotten better with other treatments. Typically, participation in clinical trials requires no additional out-of-pocket expenses for enrolled patients. And all trials follow strict safety guidelines.
Clinical trials have contributed to major medical breakthroughs in cancer treatments. Oftentimes, they are conducted in collaboration with other cancer centers, academic institutions and national consortiums, including the National Surgical Adjuvant Breast and Bowel Project, Eastern Cooperative Oncology Group, American College of Surgeons Oncology Group, Radiation Therapy Oncology Group, Clinical Trials Support Unit and Hoosier Oncology Group.
At IU Health Goshen Center for Cancer Care, clinical trials are a normal and important part of treatment. Therefore, we feel obligated to talk with patients about a clinical trial, if they could benefit. Although we offer the best current therapies, we realize that by participating in a study, our patients could further benefit from an advanced form of treatment only available within a clinical trial.
Ensuring patient safety
Clinical trial treatments at IU Health Goshen Center for Cancer Care have already been established as safe. However, patients are still carefully monitored by oncology specialists. Our most common trials offered to our patients study a new treatment’s effectiveness or compare it to the best available treatment. In some trials, the risks are known because the medicine under review is already commercially available. It’s being tested to determine whether it works better when combined with another medicine or given in a different way.
Patients can take comfort knowing that clinical trials at IU Health Goshen Center for Cancer Care are conducted by highly qualified, experienced medical professionals. And as always, our treatment philosophy is that the patient and family are an integral part of the decision-making process.
Strengthening results through research
Our strong commitment to clinical research also is supported by an equally strong Institutional Review Board (IRB). The IRB is a panel of scientifically trained members, community leaders, members of the clergy and other professionals whose responsibilities include developing guidelines and making recommendations for the research procedures offered to patients. This board aims at the highest ethical and technical standards of cancer research based on the following principles:
- Voluntary consent of the patient is essential.
- Results will advance the fight against cancer today.
- Trials will avoid all unnecessary suffering and injury.
- Degree of risk never outweighs potential benefits to the patient.
- Studies are undertaken only by qualified medical professionals.
Call our Oncology Information Specialists for more information about our current clinical studies, 888.491.HOPE (4673).